MannKind CEO Michael Castagna on What's Ahead for the Biotech
MannKind Corporation's (NASDAQ: MNKD) past has been a roller-coaster ride for investors. But what about the biotech's future?
I spoke with MannKind CEO Michael Castagna recently in a wide-ranging conversation about what's going on with the company. Our discussion about MannKind's past and present challenges was featured in a previous article. Following is our conversation about what the future might hold for MannKind. Comments were lightly edited for clarity, flow, and length.
Image source: MannKind on Twitter.
Source: Fool.com
